Registration is now open for UNMC’s annual conference dealing with several different blood cancers. This year’s conference will be held Feb. 7-8 at the Hilton Omaha, 1001 Cass St.
The regional conference, sponsored by UNMC for more than a decade, is designed to update health care providers on new treatments and management of acute and chronic leukemia, thrombosis/hemostasis, lymphoma, multiple myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms as presented during the 2019 annual meeting of the American Society of Hematology. This year’s conference is called “Lymphoma Study Group & Hematology Highlights: A Post ASH Review.”
Presentations will be delivered by key leaders while allowing the opportunity for participants to be involved in the interactive question/answer sessions.
The conference is intended for physicians, nurse practitioners, physician assistants, nurses, residents, and fellows in the specialty areas of oncology, hematology, internal medicine, radiation oncology and pathology.
Download the conference agenda here.
For more information on the conference and to register, visit the conference website.
Two UNMC/Nebraska Medicine oncologists — Philip Bierman, M.D., professor, and Lori Maness-Harris, M.D., associate professor — are co-chairing this annual conference.
This certified continuing education conference is accredited by the UNMC Center for Continuing Education and College of Nursing Continuing Nursing Education.